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AIDS is one of the most significant health care problems worldwide. Due to the difficulty and 
costs involved in treating HIV, preventing infection is of paramount importance in controlling the 
AIDS  epidemic.  The  main  purpose  of  this  paper  is  to  explore  the  potential  of  using  Data 
Envelopment  Analysis  (DEA)  to  establish  international  comparisons  on  the  efficiency 
implementation of HIV prevention programmes. To this effect we use data from 52 low- and 
middle-income countries regarding the prevention of mother-to-child transmission of HIV. Our 
results indicate that there is a remarkable variation in efficiency of prevention services across 
nations, suggesting that a better use of resources could lead to more and improved services, and 
ultimately,  prevent  the  infection  of  thousands  of  children.  These  results  also  demonstrate  the 
potential strategic role of DEA for the efficient and effective planning of scarce resources to fight 
the epidemic. 
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The epidemic caused by the human immunodeficiency virus (HIV) is currently 
one of the greatest public health problems worldwide. It is estimated that in 2009 
alone, 33.3 million people were living with HIV/AIDS, 2.6 million were newly 
infected with HIV and 1.8 million died from AIDS [1]. Although the majority of 
the disease burden remains in sub-Saharan Africa, the number of HIV-infected 
people is rapidly increasing in other regions, especially in Eastern Europe and 
Central Asia. 
 
Due to the difficulty and costs involved in treating HIV, preventing infection is of 
paramount importance in controlling the AIDS epidemic. In particular, effective 
prevention measures can reduce new infections, the incidence of the disease and, 
consequently, the number of people that will require treatment. Whilst appropriate 
prevention measures can change the course of the epidemic, they require very 
substantial  amounts  of  resources.  It  is  estimated  that  the  average  cost  of 
preventing an infection is US $3,923 [2]. Given the limited resources available to 
healthcare systems in many of the most affected countries, the implementation of 
efficient and effective HIV prevention interventions is vital for policy makers and 
health care managers. It is therefore imperative to identify the most effective HIV 
prevention strategies as well as the most efficient ways of allocating the scarce 
resources available to these strategies.  
 
Resource  allocation  models  have  been  developed  over  the  years  intended  to 
inform on allocation strategies that might improve the overall effectiveness of 
HIV prevention efforts. For some recent examples, the reader is referred to Lasry 
et al. [3], Earnshaw et al. [4] and Brandeau et al. [5]. However, as pointed out by 
Rauner and Brandeau [6], determining how best to spend limited resources on 
HIV prevention programmes in different regions of the world is a challenging 
task. One way of overcoming this challenge and obtain useful information for 
decision  making  consists  of  identifying  best  practices  that  can  be  shared  to 
promote  improvements.  Benchmarking  exercises  to  identify  best  practices 
amongst  health  care  providers  within  a  country  or  across  countries  have  the  
potential  to  provide  essential  information  for  an  improved  allocation  of  HIV 
prevention funds. 
 
The  identification  of  best  practice  is  not,  however,  straightforward.  Although 
some international comparisons have been carried out in recent years to do so, the 
approaches adopted have tended to rely on two major types of analysis: one that 
focuses on specific interventions and compares the relative costs and benefits of a 
particular  prevention  programme  against  the  other  alternatives  (e.g.  Beck  and 
Miner [7]; Harling et al. [8]), and another that focuses on data aggregated at the 
country level and uses multiple performance indicators to show the progress that 
is  being  made  by  each  country  towards  HIV  prevention  (e.g.  UNAIDS  [1]). 
Whilst valuable, these approaches present limitations in carrying out comparative 
analyses and in identifying best practice. The former is strongly impacted by the 
range of prevention strategies and geographic settings examined, ignoring the fact 
that one intervention might not be efficient in some countries but be efficient in 
others. The latter does not usually account for the fact that some countries might 
be better than others according to certain indicators, while poorer according to 
others,  making it difficult to  derive  a single  aggregate measure of the overall 
performance of each of these countries in fighting the HIV epidemic.  
 
The main purpose of this paper is to address these limitations by exploring the 
potential of using Data Envelopment Analysis (DEA) to establish international 
comparisons on the efficiency of HIV prevention, focusing on mother-to-child 
transmission, which is one of the strategies given high priority in battling the HIV 
epidemic.  For an overview of the most important types of HIV/AIDS prevention 
and treatment interventions, the reader is referred to Rauner and Brandeau [6]. 
Mother-to-child  transmission  occurs  when  an  HIV  positive  woman  passes  the 
virus to her baby during pregnancy, labour and delivery, or by breastfeeding. It is 
estimated  that  without  appropriate  prevention  and  treatment,  around  15  to  30 
percent  of  babies  born  to  HIV  positive  women  will  contract  HIV  during 
pregnancy and delivery. A further 5 to 20 percent will become infected through 
breastfeeding  [9].  It  is,  therefore,  fundamental  to  ensure  that  mother-to-child-
transmission interventions which counsel and test pregnant women for HIV, offer 
antiretroviral  medications  to  both  the  mother  and  infant  to  prevent  HIV  
transmission,  and  often  provide  substitute  feeding  programmes  to  prevent 
transmission through breastfeeding, are as efficient and effective as possible. An 
efficient and effective use of resources in this particular context has the potential 
to save the lives of thousands of children each year. 
 
 
2. Assessing Efficiency of Mother-to-Child HIV Prevention  
 
In recent years, we have witnessed remarkable progress in the fight against the 
mother-to-child  transmission  of  HIV,  with  the  AIDS  Annual  Report  [1] 
documenting a significant decrease in the infection rates among children born to 
mothers living with HIV. According to this report, in 2009, an estimated 370,000 
children contracted HIV during the perinatal and breastfeeding period, down from 
500,000 in 2001. Mother-to-child HIV prevention has played a key role in this 
decrease. Unfortunately, however, this success has not been shared to the same 
extent  by  all  countries.  Whilst  in  high-income  countries  mother-to-child  HIV 
transmission has been virtually eliminated thanks to effective prevention and care, 
the number of children infected in low- and middle-income countries is still very 
high. This might be explained in part by the fact that coverage of antenatal care 
services and other services  for preventing mother-to-child transmission  among 
women living with HIV varies considerably across nations. However, the fact that 
infection rates also vary considerably among low- and middle-income countries, 
seems  to  indicate  that  the  resources  allocated  to  prevention  have  been  more 
efficiently and effectively used in some countries than in others. 
 
The need to use the resources allocated to HIV prevention efficiently can hardly 
be overstated. As emphasised by Appleby and Thomas [10] and Flessa [11], an 
inefficient use of resources in the health care context means not only that money 
is wasted, but more importantly that the opportunity is lost to save lives, avert 
pain,  and  provide  care  to  those  in  need.  The  search  for  efficiency  and 
effectiveness in the use of resources has been a key driving force for many of the 
OR/MS science applications in the health care sector and for the emergence of 
important  publications  in  this  area  (see,  for  example,  Ozcan  and  Smith  [12]).  
Simultaneously with this call for more efficiency and effectiveness in health care, 
a call for a further shift in the balance between prevention and treatment has also 
been spread, with some authors acknowledging that OR/MS techniques have an 
important role to play in helping this shift towards more prevention (e.g. Royston 
[13]).  While  these  calls  apply  to  all  health  care  areas,  they  are  particularly 
meaningful  in  the  case  of  the  HIV/AIDS  epidemic.  The  Committee  on  HIV 
Prevention Strategies in the United States pointed out that decisions regarding the 
allocation of HIV prevention funds represent the single most important set of HIV 
prevention decisions made [14]. However, as emphasised by Kaplan and Merson 
[15: 1907] it is important to bear in mind that HIV “resource allocation is not 
simply an argument for how to divide the pie; some allocations are arguably better 
than others.”  
 
Considering  that  an  efficient  and  effective  allocation  of  resources  is  a  key 
ingredient in controlling the HIV epidemic, and that there is some compelling 
evidence suggesting that the unit cost of HIV prevention programmes may be both 
higher and more variable than some estimates suggest (e.g. Marseille et al. [16]), 
it is fundamental for researchers to carry out comparative analyses across nations 
in order to identify best practice. The research we discuss in this paper aims to 
shed some light on this issue by comparing the resources spent on mother-to-child 
HIV prevention by several countries with the services provided.  
 
Although  there  is  an  increasing  and  highly  relevant  body  of  literature  on  the 
efficiency  and/or  effectiveness  of  specific  prevention,  treatments  and  care 
programmes (see for example, Harling et al. [8]), the number of studies assessing 
and comparing how efficiently different countries are using the available funds to 
combat the epidemic are very rare. Furthermore, when comparisons are made, 
these tend to rely on the use of multiple performance indicators or ratios rather 
than on the use of a single aggregate measure of the overall performance of each 
country. This problem could be addressed if it was possible to reach an agreement 
on  the  relative  importance  of  the  various  performance  indicators.  This  is, 
however, seldom the case as the importance of each indicator is dependent upon 
the perspective taken and upon the priorities of the countries under evaluation. 
  
Data envelopment analysis, developed by Charnes, Cooper and Rhodes in 1978  
[17] is a non-parametric linear programming technique which has proved very 
effective in addressing this limitation and it is one of the most important and 
widely used approaches to measure the performance of homogeneous decision 
making units (DMUs) performing the same task. This technique uses a production 
metaphor. It considers that each DMU is engaged in a transformation process, 
where  by  using  some  inputs  (resources)  it  is  trying  to  produce  some  outputs 
(goods or services). With the provision of these services, the DMU intends to 
achieve certain outcomes, which measure the impact of the services on the users. 
One of the interesting features of DEA is that it allows each unit to identify a 
benchmarking  group;  that  is,  a  group  of  units  that  are  following  the  same 
objectives  and  priorities,  but  performing  better.  In  this  respect  DEA  aims  to 
respect the priorities of each DMU by allowing each one of them to choose the 
weight structure for inputs and outputs that most benefits its evaluation. As a 
result, it aims to classify each unit in the best possible light in comparison to the 
other units.  
 
The formulation of the DEA problem, under variable returns to scale, with output 
orientation, for DMU 0, as proposed by Banker et al. [18] is as follows:   
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In this problem, n is the number of DMUs; s is the number of outputs and m is the 
number of inputs; Yr0 is the amount of output r generated by unit 0 and Xi0 is the 
amount of input i used by unit 0;  j 
 is the intensity variable for DMU j. In case  






j    is  not  included  in  the  formulation  above,  the  model 
assumes a constant returns to scale (CRS) technology. 
 
The score       obtained 
from the solution to this linear programming problem is the maximum rate of 
proportional expansion in all outputs of DMU 0, without decreasing its inputs. 
The efficiency rate of DMU 0 can be obtained by calculating 1/     , and will be 
equal to 1 if the DMU is efficient, and smaller than 1 if the DMU is inefficient 
when  compared  with  the  other  DMUs.  A  comprehensive  review  of  the  DEA 
technique can be found in Cooper et al. [19, 20]. 
 
Since its advent in 1978, this method has been the subject of several theoretical 
developments  and  has  been  extensively  applied  in  many  sectors  including 
education, finance, agriculture, sports, marketing and manufacturing, to name just 
a few. There have also been several documented applications of DEA in the health 
care sector. The Health Care Management Science Journal, amongst others, has 
been an important forum for the dissemination of these applications. In two recent 
special issues of this journal dedicated to contemporary health care applications in 
OR/MS and to operational research applied to health services, the reader can find 
several good examples showing the use of DEA in this context (e.g. Ozgen and 
Ozcan  [21];  O’Neill  and  Dexter  [22];  and  Langabeer  and  Ozcan  [23]). 
Hollingsworth et al. [24], Hollingsworth [25], Chilingerian and Sherman [26] and 
more recently Hollingsworth [27], review several of the DEA applications in the 
health care context.  
 
Whilst the use of DEA in the health care sector has been prolific, to the best of our 
knowledge, no studies have been documented on the use of DEA to compare the 
efficiency of countries in using HIV prevention resources. The only exception in 
this area is the study by Zanakis et al. [28], which examines the impact of major 
socio-economic  factors  on  HIV/AIDS  indicators  and  assesses  each  country’s 
efficiency in battling the epidemic. In so doing, this study makes an important 
contribution in this under researched area, not only because it is the first one using 
DEA to assess the efficiency of nations in battling HIV but also because it points 
out  that  research  on  HIV/AIDS  should  include  both  individual  and  social-
economic factors, to better understand the development of the global epidemic.   
 
The  research  we  discuss  in  this  paper  presents,  however,  some  important 
departures from Zanakis et al.’s study. Firstly, the assessment of each country’s 
efficiency in preventing HIV infections is the main focus and objective of our 
research. In Zanakis et al.’s study this objective was part of a broader agenda and 
played  a  fairly  marginal  role.  Secondly,  our  study  focuses  exclusively  on  the 
efficiency  of  HIV  prevention,  whilst  theirs  does  not  seem  to  distinguish 
prevention from treatment.  However, our study, in line with the findings reported 
by Beck [29] and Piot et al. [30] acknowledges that the containment of the HIV 
epidemic  requires  a  global  strategy  which  combines  effective  prevention  with 
treatment and care programmes. This implies that some variables related to HIV 
treatment and care will be considered in the analysis as they have a significant 
impact  on  HIV  transmission.  Thirdly,  the  model  we  propose  is  considerably 
different  from the one they have used.  In particular, we focus  on a particular 
programme and use variables more directly related with HIV prevention than the 
surrogate general health variables used by Zanakis and colleagues. Finally, our 
study, by using data for 2008, aims to offer an updated overview of the efficiency 
of recent efforts in battling the epidemic as the analysis carried out by Zanakis et 
al. used data from 1998. By doing this, our research complements this previous 
work  and  makes  an  important  contribution  to  knowledge.  Zanakis  et  al. 
recognised  that  their  study  was  preliminary  and  that  further  additional  multi-
country  studies  in  global  efficient  strategies  for  combating  HIV/AIDS  were 
needed.  As  emphasised  by  Harling  et  al.  [8],  establishing  multi-country 
comparative analyses on the use, cost and outcome of HIV prevention services, 
especially in middle and lower income countries, is critical to fill some of the 
large gaps which exist in the scientific literature on HIV interventions in these 
countries. These gaps have limited the ability for the existing literature to guide 
policy makers in those settings where the epidemic is most intense. As pointed out 
by Harling et al. [8: 372] “increased research in such settings and dissemination of 
their  findings  is  urgently  required,  especially  given  the  need  for  intensified 
prevention strategies to complement the scaling up of HIV treatment and care 
services in these countries.” 
  
The  framework  we  propose  to  assess  the  efficiency  of  mother-to-child  HIV 
prevention  and  in  this  way  contribute  to  the  extant  literature,  draws  on  the 
principles  of  the  Prevent  AIDS  Network  for  Cost-Effectiveness  Analysis 
(PANCEA) approach [16]. PANCEA is a five-country study, funded by the U.S. 
National  Institute  of  Health,  aimed  at  providing  information  for  an  improved 
allocation  of  HIV  prevention  funds  in  low-  and  middle-income  countries.  In 
particular,  the  PANCEA  approach  is  designed  to  generate  three  indicators  of 
efficiency for each prevention programme: cost per unit of service provided, cost 
per reduction in risky behaviours, and cost per HIV infection prevented. Figure 1 











 Source: Adapted from Marseille et al. [16]. 
 
Figure 1. The PANCEA Conceptual Framework 
 
 
The first indicator of efficiency measures the cost per unit of service provided by 
a  particular  programme  or  intervention  (e.g.  cost  per  pregnant  woman  who 
received voluntary counselling and testing). The second indicator of efficiency 
assesses the cost of reducing risky behaviours (e.g. cost per newly protected sex 
episode). The third indicator measures the cost effectiveness of the programme by 
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The analysis we discuss  in  this paper focuses essentially on the Efficiency of 
Services  Provision  regarding  mother-to-child  HIV  prevention.  In  spite  of  its 
limited scope, it can provide essential information for an improved allocation of 
HIV  prevention  funds  as  there  is  compelling  evidence  showing  that  the  three 
indicators above are strongly linked. In particular, behavioural evaluations have 
shown that the more units of service are provided the lower the risky behaviours 
tend to be. Epidemic modelling has shown, in turn, that reduction in behavioural 
risk contributes to reduce HIV transmission. Therefore, it seems reasonable to 
assume that by comparing the efficiency of service provision across countries and 
identifying the best performers, we are able to identify those countries that are 
most likely using the resources in a more effective way. This is, however, the 
subject of further research. Considering that our study focuses on the efficiency of 
nations in implementing a particular prevention programme whilst the PANCEA 
project focuses on the efficiency of particular programmes when compared with 
alternative  interventions,  we  believe  that  these  two  types  of  approaches  can 
together  provide  a  richer  understanding  of  efficiency  in  HIV  prevention  and, 
consequently, a better foundation for policy recommendations. 
 
 
3. Empirical Analysis 
 
3.1. The DEA Model 
 
The choice of appropriate input and output variables is a fundamental step in DEA 
analysis. Whilst several input indicators can be used in this context, the costs of 
running  mother-to-child  HIV  prevention  interventions  is,  perhaps,  the  most 
relevant. These costs are usually grouped into three major categories: personnel 
expenses (e.g. salaries and other compensation paid to the personnel involved in 
the  prevention  programme),  other  recurrent  goods  and  services  expenses  (e.g. 
medicines,  laboratory  tests,  supplies,  office  and  administrative  expenses,  and 
utilities),  and  capital  expenses  (e.g.  medical  equipment,  furniture,  vehicles, 
computers, and buildings). In this research we use the variable “Prevention of  
mother-to-child  HIV  transmission  domestic  spending  from  public  and 
international financing sources (US$)” as the only controllable input.  
 
The resources allocated to preventing mother-to-child HIV transmission can have 
several uses as various interventions are usually developed as part of the core 
response to achieve this objective. The choice of the most appropriate outputs 
should, therefore, aim to include in the DEA model those outputs thought to have 
the greatest  potential to reduce mother-to-child HIV transmission. Taking into 
account this principle, the model we propose has four main outputs.  
 
The  first  output  variable  in  our  model  is  the  “Reported  number  of  pregnant 
women tested for HIV”. As pointed out by the Joint United Nations Programme 
on HIV/AIDS [31] voluntary counseling and testing are an essential part of any 
prevention  of  a  mother-to-child  transmission  strategy.  HIV  testing  is  critical 
because pregnant women who do not know they are HIV positive cannot benefit 
from appropriate prevention interventions. Considering that the protective benefit 
of antiretroviral drugs is diminished when babies continue to be exposed to HIV 
through  breastfeeding,  HIV  positive  mothers  are  advised  not  to  breastfeed 
whenever they have safe, affordable alternatives to breastfeeding. HIV testing and 
counseling  offer  significant  opportunities  to  provide  important  advice  to  HIV 
positive mothers on the risk and benefits of different infant feed options allowing 
them  to  make  better  informed  decisions  about  the  most  suitable  options  and, 
ultimately, contributing to lower mother-to-child HIV transmission. In addition, 
when  testing  is  carried  out  and  post-testing  counseling  is  given,  valuable 
information and support is also passed to women not infected in order to avoid 
future infection. Unless the measures we discuss bellow (and which are captured 
by the other three output variables) are backed up by effective HIV testing and 
counseling  programmes,  their  full  potential  to  save  babies’  lives  will  not  be 
achieved. 
 
The second output variable accounts for the “Number of pregnant women living 
with  HIV  who  received  antiretrovirals  for  preventing  mother-to-child 
transmission”.  The  administration  of  antiretroviral  drugs  to  pregnant  women 
decreases the viral load in the mother and is highly effective at preventing mother- 
to-child transmission (see, for example, Bryson [32]). Pregnant women who are 
HIV  positive  are  usually  advised  to  begin  antiretroviral  treatment  either 
immediately  or  after  the  first  trimester.  Under  the  2010  World  Health 
Organization guidelines, all HIV positive mothers, identified during pregnancy, 
should receive an extensive course of antiretroviral drugs to prevent mother-to-
child transmission.  
 
In order to lower the risk of transmission even further and/or reduce HIV-related 
morbidity  and  mortality,  it  is  important,  that  newborn  babies  who  have  been 
exposed to the virus, are also given a course of prophylactic treatment for the first 
few days or weeks with antiretrovirals and/or co-trimoxazole, respectively. Co-
trimoxazole is a widely available antibiotic that substantially reduces HIV-related 
morbidity and mortality in both adults and children. As pointed out by Zachariah 
et al. [33: 686], “prophylaxis with co-trimoxazole is a recommended intervention 
of proven benefit that could serve not only as an initial step towards improving 
paediatric care in young children with limited access to antiretroviral treatment, 
but also as an important complement to antiretroviral therapy in resource-limited 
settings”.  Marseille  et  al.  [34]  have  also,    more  than  a  decade  ago,  provided 
evidence  suggesting  that  the  administration  of  antiretrovirals  to  mothers  and 
babies just before and soon after birth has a major potential impact on reducing 
vertical HIV transmission. In order to account for these factors, we included in 
our DEA model the following output variables: “Reported number of infants born 
to women living with HIV receiving antiretrovirals for preventing mother-to-child 
transmission” (i.e. Output 3) and “Reported number of infants born to women 
living with HIV receiving co-trimoxazole prophylaxis within two months of birth” 
(i.e. Output 4).  
 
In  carrying  out  a  comparative  analysis  of  countries  in  battling  the  HIV/AIDS 
epidemic it is also important to bear in mind that there are socio-economic factors 
(i.e. exogenous  conditions) that are not directly controllable by the prevention 
authorities  but  can  explain  differences  in  efficiency  and  ultimately  help 
understand the development of the epidemic in each country. Consequently, it is 
important  to  include  in  the  analysis  nondiscretionary  variables  (inputs  and/or 
outputs) that will assure comparable technologies. According to Quinn [35], to  
control AIDS, countries must not only promote changes in individual behaviour 
but  also  address  socio-economic  issues.  In  fact,  considerable  HIV/AIDS 
differences  among  nations  have  been  attributed  to  exogenous  conditions  like 
nation’s wealth, migration from rural to urban areas, education, access to health 
services and drug use. For example, Zanakis et al. [28], in exploring the effects 
that socio-economic factors have on the development of the HIV/AIDS epidemic, 
found  evidence  that  countries  with  lower  population  density  that  manage  to 
provide  better  health  system  performance  and  per  capita  support  with  not 
necessarily higher GNP and better media information are more likely to exhibit 
lower HIV/AIDS indicators.  
 
In  the  particular  case  under  analysis,  it  is  acknowledged  that  good  quality 
HIV/AIDS education is fundamental to eliminate myths and misunderstandings, 
and to counter stigma and discrimination against pregnant women. It is likely that 
in countries with lower literacy rates, pregnant women will be less willing to carry 
out  voluntary  testing  and  counseling  for  HIV,  which  might  result  in  poorer 
efficiency results when compared with nations with higher literacy rates. In order 
to  account  for  this  non-controllable  factor,  and  allow  fairer  comparisons,  we 
decided  to  include  a  proxy  variable  to  capture  the  level  of  education  in  the 
population. We have used the variable “Number of people aged 15 years and older 
who can, with understanding, both read and write a short simple statement on 
their everyday life”. This variable resulted from the product of the literacy rate of 
each country and the respective population aged 15 years and older.  
 
In summary, the DEA model we propose to assess the efficiency of mother-to-
child-HIV  transmission  interventions  and  which  was  developed  based  on  the 
literature review and on the discussion presented above, is the one presented in 











Table 1: DEA model to assess efficiency of mother-to-child HIV  
transmission prevention 
 
Inputs  Outputs 
 Input  1:  Prevention  of  mother-
to-child  HIV  transmission 
domestic  spending  from  public 
and  international  financing 
sources; 
 Input 2: Number of people aged 
15 years and older who can, with 
understanding,  both  read  and 
write a short simple statement on 
their everyday life. 
 Output 1: Reported number of pregnant 
women tested for HIV; 
 Output 2: Number of pregnant women 
living  with  HIV  who  received 
antiretrovirals for preventing mother-to-
child transmission; 
 Output  3:  Reported  number  of  infants 
born  to  women  living  with  HIV 
receiving  antiretrovirals  for  preventing 
mother-to-child transmission; 
 Output  4:  Reported  number  of  infants 
born  to  women  living  with  HIV 
receiving  co-trimoxazole  prophylaxis 




3.2. Data and Efficiency Results 
 
The data used in this study refers to the activity of 52 low- and middle-income 
countries  regarding  mother-to-child  HIV  prevention  in  2008.  These  countries 
belong  to  various  geographic  regions.  In  particular,  our  sample  included  27 
countries from sub-Saharan Africa, 6 from East, South and South-East Asia, 9 
from Europe and Central Asia and 10 from Latin America and the Caribbean. 
 
Data were collected from a variety of international public sources including the 
Joint  United  Nations  Program  for  HIV/AIDS,  United  Nations  Development  
Program and World Health Organization. Table 2 presents a descriptive summary 
of the data for the 52 countries considered in the analysis. 
 
Table 2 - Summary statistics for the variables used in the study 
 
 
Input 1  Input 2  Output 1  Output 2  Output 3  Output 4 
Average  2665009  29742334  350066  5247  4008  1322 
St Dev  4928659  81269484  686742  11411  8366  3479 
Max  29332921  550995518  4234401  59601  41253  21841 
Min  1035  84288  5335  6  0  0 
 
 
From  this  table,  one  can  see  that  there  are  considerable  discrepancies  across 
countries. For example, whilst the average spending on prevention of mother-to-
child HIV transmission is approximately 2.7 million US$ per country, some have 
spent considerably more than others. For instance, Sao Tome and Principe reports 
the lowest  annual  spending on this  prevention  programme (1035 US$), whilst 
Kenya the highest (29.3 million US$). From another side, we can see that the 
estimated number of people aged 15 years and older who can, with understanding, 
both read and write is also highly variable between nations. This is explained in 
part by the fact that some countries like India are highly populated compared to 
other, small, countries (e.g. Sao Tome and Principle). Considering that there are 
remarkable discrepancies at the level of the inputs, it is not surprising that these 
will also exist at the level of the outputs. As shown in Table 2, the number of 
pregnant women tested for HIV and the number found to be HIV-positive and 
receiving antiretrovirals for preventing mother-to-child transmission also varies 
considerably  among  the  52  nations  on  our  sample.  The  same  applies  to  the 
number  of  infants  receiving  antiretrovirals  and/or  co-trimoxazole.  In  this 
particular  case,  it  is  important  to  mention  that  the  zero  value,  shown  as  the 
minimum, indicates that the countries are not providing these medicines to infants 
or, most likely, that data were not reported, and therefore, it was assumed as being 
zero. Considering that the model has four outputs and no weight restrictions are 
imposed  on  the  outputs,  we  believe  that  the  results  obtained  with  the  DEA 
analysis will not be considerably affected by this assumption. 
  
In order to assess each nation’s efficiency, we have used the PIM DEA software 
[36] and a DEA model with output orientation. This is justified by reasoning that 
countries should aim to increase the level of service provision, given the spending 
and  the  population  education.  Furthermore,  we  have  used  an  assumption  of 
variable returns to scale (VRS), as proposed by Banker et al. [18]. According to 
Marseille et al. [37] the assumption of constant unit costs may result in substantial 
inaccuracies as  they found compelling evidence that  efficiency increased (unit 
costs  decreased)  with  scale,  across  all  countries  and  interventions  examined. 
Brandeau et al. [5] and Brandeau and Zaric [38], also discuss the issue of scale in 
HIV  prevention  programmes,  pointing  out  that  the  relationship  between 
investment  on  HIV  prevention  and  HIV  infections  averted  may  not  be  linear, 
which  indicates  that  increased  spending  on  a  prevention  programme  may  not 
always be cost effective. We have also used a weight restriction on the input side, 
in order to prevent countries from attributing a null weight to the variable related 
to spending. This restriction imposes that the virtual weight given by each country 
to the non-controllable input (i.e. number of people aged 15 years and older who 
can, with understanding, both read and write a short simple statement on their 
everyday life) cannot exceed the virtual weight given to the controllable input (i.e. 
prevention of mother-to-child HIV transmission domestic spending from public 
and  international  financing  sources).  The  development  of  this  virtual  weight 
restriction follows the approach proposed by Sarrico and Dyson [39]. 
 
Table 3 presents the preliminary results from the DEA model discussed above. It 
presents the efficiency scores for each one of the 52 countries during 2008 as well 
























Angola  19.95  35.86  55.63  DRS 
Argentina  16.01  58.35  27.44  DRS 
Armenia  14.43  26.23  55.01  DRS 
Azerbaijan  19.98  61.45  32.51  DRS 
Belarus  14.89  47.2  31.55  DRS 
Benin  68.67  83.61  82.13  DRS 
Bolivia (Plurinational State of)  6.12  16.79  36.45  DRS 
Botswana  100  100  100.00  CRS 
Brazil  20.25  100  20.25  DRS 
Burkina Faso  57.68  83.89  68.76  DRS 
Burundi  23.07  23.22  99.35  IRS 
Cambodia  15.08  32.77  46.02  DRS 
Cameroon  100  100  100.00  CRS 
Central African Republic  72.62  74.32  97.71  IRS 
Chad  17.11  17.31  98.84  IRS 
Chile  7.39  26.65  27.73  DRS 
Colombia  8.07  34.72  23.24  DRS 
Congo  17.49  18.35  95.31  DRS 
Côte d'Ivoire  100  100  100.00  CRS 
Democratic Republic of the Congo  11.73  34.42  34.08  DRS 
El Salvador  18.78  39.78  47.21  DRS 
Equatorial Guinea  55.06  60.97  90.31  IRS 
Eritrea  44.09  48.17  91.53  DRS 
Georgia  15.82  30.92  51.16  DRS 
Ghana  37.93  77.42  48.99  DRS 
Guinea-Bissau  18.63  18.66  99.84  CRS 
Honduras  19.67  42.67  46.10  DRS 
India  100  100  100.00  CRS 
Indonesia  56.73  66.55  85.24  IRS 
Kenya  54.9  100  54.90  DRS 
Kyrgyzstan  54.56  72.53  75.22  DRS 
Lesotho  68.76  70.16  98.00  IRS 
Madagascar  100  100  100.00  CRS 
Malawi  100  100  100.00  CRS 
Mali  100  100  100.00  CRS 
Mexico  7.39  32.44  22.78  DRS 
Mozambique  100  100  100.00  CRS 
Myanmar  7.23  21.96  32.92  DRS 
Niger  100  100  100.00  CRS 
Nigeria  14.9  56.98  26.15  DRS 
Paraguay  20.34  33.08  61.49  DRS 
Peru  16.74  61.99  27.00  DRS 
Republic of Moldova  15.44  26.92  57.36  DRS 
Russian Federation  12.55  68.02  18.45  DRS 
Rwanda  70.8  97.3  72.76  DRS 
Sao Tome and Principe  100  100  100.00  CRS 
Senegal  28.75  51.65  55.66  DRS 
Tajikistan  8.43  19.6  43.01  DRS 
Thailand  16.81  58.96  28.51  DRS 
Togo  44.78  45.43  98.57  IRS 
Ukraine  17.6  57.76  30.47  DRS 
Viet Nam  4.96  22.14  22.40  DRS 
          Average  41.19596  58.79231  63.8093 
  St Dev  34.37185  29.74814  30.46101 
  Max  100  100  100 
  Min  4.96  16.79  18.45046 
                 Note: IRS=increasing returns to scale; CRS=constant returns to scale; DRS=decreasing returns to scale.  
 
Due to the exploratory nature of this research, some caution needs to be taken 
when we analyse these  results.  In spite of this, the results  shown on  Table 3 
highlight some relevant aspects about the efficiency of each country in preventing 
mother-to-child HIV transmissions.  
 
As can be seen from Table 3, we have broken down the technical efficiency score 
into  pure  technical  efficiency  and  scale  efficiency.  In  2008,  the  average  total 
efficiency score of the 52 countries was only 41%, with a standard deviation of 
approximately  34%,  which  indicates  that  there  are  considerable  differences 
between countries and remarkable potential for improvement in some of them. In 
our study, only ten countries are classified as efficient under the assumption of a 
CRS  technology:  Botswana,  Cameroon,  Côte  d’Ivoire,  India,  Madagascar, 
Malawi, Mali, Mozambique, Niger and Sao Tome and Principe. When we allow 
VRS, which seems to be a more appropriate assumption to adopt in this context, 
as explained previously, the average pure technical efficiency score is 58.8% and 
the number of efficient countries increases to twelve. This means that we have 
only  two  countries  (Brazil  and  Kenya)  that  are  technically  efficient  while 
operating under sub-optimal scale sizes. Both countries operate under decreasing 
returns to scale (DRS), which suggests that a smaller scale of operation (i.e. a 
lower  domestic  spending  on  the  prevention  of  vertical  transmission  of  HIV) 
would lead to a greater ratio of outputs over inputs. In fact, with regard to most of 
the countries that are technically inefficient, the DEA results suggest that they 
could  benefit  from  decreasing  their  size  of  operation.  These  results  seem  to 
counter the findings of Marseille et al. [37], who found evidence that efficiency 
increased  with  scale.  The  only  countries  under  analysis  which  could  benefit 
significantly from operating at a higher scale are Equatorial Guinea and Indonesia 
(please refer to Table 3). Whilst scale seems to play an important role on the 
efficiency  of  some  countries  (e.g.  Brazil,  Kenya,  Rwanda),  others  (e.g.  Chad, 
Congo,  Guinea-Bissau,  Togo)  could  benefit  mostly  from  a  better  use  of  the 
resources  allocated  to  preventing  mother-to-child  HIV  transmission,  basically 
maintaining their size of operation.  
  
In  analysing  the  efficiency  results  it  is  also  important  to  identify  the  optimal 
weight structure chosen by each country. Despite the fact that the DEA model 
may  yield  alternative  optimal  solutions  for  the  weights,  the  different  optimal 
weights  identified  can  provide  useful  information.  For  instance,  the  different 
optimal  output  weight  profiles  are  useful  to  identify  different  service  delivery 
strategies. Table 4 illustrates some of these different strategies. 
 
Table 4: Virtual weights attributed to the outputs by some countries under the 
VRS assumption (%) 
     
 
Output 1  Output 2  Output 3  Output 4 
Botswana  8,2  8,2  54,4  29,2 
Cameroon  25  25  25  25 
Côte d'Ivoire  0  100  0  0 
Equatorial Guinea  0  100  0  0 
Guinea-Bissau  44,5  55,5  0  0 
India  100  0  0  0 
Indonesia  0  0  100  0 
Kenya  36,6  5,4  52,6  5,4 
Madagascar  100  0  0  0 
Malawi  25  25  25  25 
Mozambique  0  0  100  0 
Nigeria  33,5  0  49,7  16,8 
Sao Tome and Principe  25  25  25  25 
Togo  0  0  100  0 
 
 
As shown in Table 4, several different output weight profiles can be identified. 
Whilst some countries placed all the output weight in one of the outputs (e.g. Côte 
d'Ivoire, Indonesia, Madagascar), other countries distributed the weights between 
several or all outputs (e.g. Botswana, Cameroon, Kenya). The analysis of the 
results for the 52 countries shows that a large number of countries (22) have 
placed all the output weight on the output variable: “Reported number of pregnant 
women  tested  for  HIV”.  India  and  Madagascar  are  two  examples  of  these 
countries: they have been classified as efficient, and placed 100% of the output 
weight on this output. A minority of countries also present an unbalanced profile 
of output weights, by placing all their weight on one of the other three outputs. 
For example, whilst Côte d’Ivoire and Equatorial Guinea have put all their output 
weights  on  the  variable  “Number  of  pregnant  women  living  with  HIV  who  
received antiretrovirals for preventing mother-to-child transmission”, Indonesia, 
Mozambique and Togo have placed all their output weight on variable “Reported 
number of infants born to women living with HIV receiving antiretrovirals for 
preventing  mother-to-child  transmission”.  Contrasting  with  this,  we  find  three 
countries classified as efficient (Cameroon, Malawi and Sao Tome and Principe) 
that present a totally balanced weight profile, giving 25% of the weight to each 
output. The remaining countries present weights distributed unequally between 
two, three or all outputs.  
 
Another  interesting  piece  of  information  provided  by  DEA  relates  to  the 
identification of benchmarks for each of the inefficient countries. Benchmarks are 
units that are classified as efficient when applying the optimal weight structure of 
the inefficient units under analysis. For example, as illustrated on Table 5, the 
benchmarks identified for Angola are Brazil, Malawi and Mozambique. These are 
the countries that Angola should use as a reference for learning.  
 
Table 5: Peers and lambdas for some countries under the VRS assumption 
 
 
Brazil  Cameroon 
Côte 
d'Ivoire 




Angola  0.07 
   
0.707  0.286     





0.101  0.033    0.59 
Chad 
 
0.158  0.275        0.567 
Colombia  0.316 
 
0.684         
Congo 
   
0,401      0.29  0.309 
Eritrea 
 
0.043  0.087      0.533  0.337 
Mexico  0.979  0.021 
 
       
Peru  0.212 
 
0.788         
Thailand  0.5  0.326 
 
0.174       
       
       
Number of times  
country i is used  
as a peer 
21  23  24  9  4  13  10 
 
Whilst some countries serve as benchmarks for a large number of countries (e.g. 
Brazil, Cameroon, Côte d’Ivore, Niger), others are classified as efficient but do 
not serve as a reference for other countries. From the 52 countries compared, Mali 
is the only one that has been classified as efficient but does not serve as reference  
to any other country. Mali has chosen a very peculiar weight structure: it places 
almost all its output weight on the third output (i.e. reported number of infants 
born to women living with HIV receiving co-trimoxazole prophylaxis within two 
months  of  birth).  No  other  country  benefits  from  this  weight  structure,  which 
means that Mali has been classified as efficient because there is no other country 
to which it can be compared. In contrast, there are three countries that serve as 
benchmarks to more than 20 countries, presenting very robust efficiency status. 
These countries are: Côte d’Ivore, Cameroon and Brazil. These results indicate 
that  the  policies  and  service  delivery  strategies  used  by  these  three  countries 
should be identified in order to provide guidance for other countries. This is the 
subject of future research.  
 
In  addition  to  the  information  regarding  the  benchmarks  from  which  the 
inefficient countries can learn, Table 5 also provides useful information to define 
the targets to be achieved by these countries. This information is contained in the 
lambda values displayed in each of the rows of Table 5.  For example, the values 
of  the  lambdas  associated  with  Mexico  (i.e.  0.979  and  0.021)  represent  the 
proportion of the service levels of Brazil and Cameroon that Mexico is required to 
provide to become efficient. 
 
 
4 – Conclusion 
 
In spite of the remarkable progress that has been made in recent years in battling 
the HIV/AIDS epidemic, this disease still poses huge challenges for individuals, 
households and nations. It is estimated that more than 1,000 children are newly 
infected with HIV every day, and of these more than half will die as a result of 
AIDS because of a lack of access to HIV treatment [1]. Over 90 percent of the 
children living with HIV were infected through vertical transmission from mother 
to the baby during pregnancy, delivery or breastfeeding. Considering that there is 
compelling evidence that appropriate prevention and care can reduce the rate of 
these  transmissions  significantly,  it  is  imperative  that  nations  ensure  that  this  
prevention and care reaches all pregnant women and children in need and that the 
resources are used as efficiently as possible.  
 
In the academic literature there have been important contributions exploring the 
efficiency  and  cost-effectiveness  of  different  HIV  prevention  programmes, 
including  mother-to-child  transmission.  Most  of  these  contributions  have, 
however, been narrowed to a small region, a single country or parts of it, and have 
tended  to  rely  on  the  use  of  a  set  of  individual  indicators  detailing  different 
aspects of service delivery. In this paper, we have explored the potential of using 
DEA to complement the existing literature in the area. To this effect we have 
proposed a model with two inputs and four outputs to compare, using data for 
2008,  the  efficiency  of  52  low-  and  middle-income  countries  in  preventing 
mother-to-child HIV transmission.  
 
Despite the exploratory nature of the research, there are some important empirical 
findings from our study. In particular, we found wide variation in terms of the 
efficiency of service provision across nations, indicating that some countries have 
been  considerably  more  efficient  in  allocating  resources  to  preventing  HIV 
transmission  from  mother-to-child  than  others.  This  variation  ought  to  be 
investigated as our preliminary results suggest that if all countries were using their 
resources efficiently, the level of service provision could increase by around 70 
percent.  Considering  that  the  analysis  reported  in  this  paper  also  allows  the 
identification  of  suitable  learning  peers  to  each  nation,  as  well  as  targets  for 
performance improvement, we believe it can be an important catalyst for a deeper 
formative  assessment  aimed  at  identifying  the  causes  of  poor  performance, 
exploring the practices of the best performers; and based on this assessment to 
develop sound strategies for HIV prevention improvement. 
 
The  formative  implementation  of  DEA  in  this  context,  however,  faces  some 
challenges. One of the most relevant is, perhaps, data unavailability. There are 
many countries for which there is no data, and even when data exists it does not 
cover  all  the  important  variables,  or  does  not  cover  more  than  a  year.  Data 
unavailability  might  prevent  the  specification  of  appropriate  models  or  might 
prevent the inclusion of countries in the analysis which could eventually change  
the efficiency frontier. Furthermore, when no panel data exists, it is not possible to 
perform  dynamic  assessments  targeted  at  analysing  eventual  changes  in  the 
performance of nations over time. Another important challenge relates to the need 
of  including  weight  restrictions  in  the  models.  In  developing  DEA  models  to 
assess  the  efficiency  of  countries  in  implementing  particular  HIV  prevention 
policies it is important to decide whether it is acceptable to allow full flexibility in 
the  choice  of  input  and  output  weights.    Whilst  several  approaches  to  define 
weight restrictions exist, the specification of appropriate weight restrictions can be 
a very challenging task.  
 
It is important to emphasise that despite the fact that the successful application of 
DEA can be a challenge, DEA has a strong potential to contribute for performance 
improvement in this context. In particular, DEA is well suited to complement 
efficiency analyses undertaken by means of other methodologies. 
 
In conclusion, we believe that DEA is a strong analytical technique upon which to 
build and which can play an important role in the development of efficient HIV 
prevention interventions. This paper has discussed some of the insights that derive 
from the use of DEA in this particular context. However, one of the premises of 
the authors of this paper is that DEA has to be broadened in order to contribute to 
performance improvement in practice. One of the main aspects of this broadening 
relates to the need to move away from the ‘black box’ type of evaluation, by 
incorporating  the  DEA  exercise  into  case  studies  and  context-driven  research 
projects  in  order  to  facilitate  the  development  of  appropriate  models  and  the 
implementation of the results in practice. Unless the results of these models are 
taken  into  consideration  by  decision  makers  and  incorporated  into  the  policy 
making process, their purposes are not served. Further research is being carried 
out by the authors in order to meet these objectives. 
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